On May 9, 2019 the Food and Drug Administration issued a “Recommendations for Reducing the Risk of Transfusion-Transmitted Babesiosis” guidance document with a maximum 12 month implementation timeline. Per the FDA guidance document recommendations, CTS is developing a specific implementation plan for mandatory Babesia testing well before the May 8, 2020 deadline.
Check out the Communication page for the complete details by clicking the link: Communications
Just a reminder that the revised client forms implement today! Don't forget to toss your o...
The revised CTS algorithm associated with the Ortho platform is now available for review. Clie...
CTS lab staff recently participated in a Kaizen and determined emailed Daily Shipment Schedules to b...
Reminder - The CTS Reentry form, CTS-00172, will be updated on Monday July 2, 2018. It's posted ...
CTS Tampa has implemented the Ortho Vitros Anti-SARS-CoV-2 Total test which qualitatively detects an...
Honor Your StaffCelebrate Lab Week, and honor yourself and your colleagues as a vital part of the la...